The purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of soft tissue sarcoma (STS).
Drug: Olaratumab
Administered intravenously (IV)
Other Name: LY3012207
Inclusion Criteria: - Are currently receiving olaratumab and who, in consultation with their treating physician, want to continue their course of therapy. - Have metastatic or locally advanced unresectable soft tissue sarcoma not amenable to curative treatment with surgery or radiotherapy. - Have given written informed consent. - Have an absolute neutrophil count (ANC) ≥1,000/microliter. - Females of childbearing potential and males must agree to use highly effective contraceptive precautions during treatment with olaratumab and up to 3 months following the last dose of olaratumab. A highly effective method of birth control is defined as one that results in a low failure rate (that is,
Ironwood Cancer & Research Centers
Glendale, Arizona, 85306
Contact: 480-324-5262
Investigator: Elisa T Bomgaars
Marin Specialty Care, Inc
Greenbrae, California, 94904
Contact: 415-925-5000
Investigator: Barbara Galligan
The Angeles Clinic & Research Institute
Los Angeles, California, 90025
Contact: 310-231-2118
Investigator: Lawrence Piro
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, 90027
Contact: 323-783-9013
Investigator: Karen W Kwan
Kaiser Permanente West Los Angeles
Los Angeles, California, 90034
Contact: 323-857-2713
Investigator: Cannon Milani
Kaiser Permanente Moreno Valley
Moreno Valley, California, 92555
Contact: 626-564-3506
Investigator: Vishal Ranpura
University of Colorado Health Hospital
Aurora, Colorado, 80045
Contact: 720-848-0300
Investigator: Victor Villalobos
UCHealth Cancer Center
Fort Collins, Colorado, 80528
Contact: 970-297-6150
Investigator: Diana Medgyesy
Baptist MD Anderson Cancer Center
Jacksonville, Florida, 32207
Contact: 904-202-7300
Investigator: William Hammond
Mayo Clinic in Florida
Jacksonville, Florida, 32224
Contact: 904-953-2000
Investigator: Steven Attia
Ocala Oncology, P.A.
Ocala, Florida, 34474
Investigator: Ketan D Doshi
Florida Cancer Specialists
Orlando, Florida, 32804
Contact: 407-898-5452
Investigator: Yaman Suleiman
Orlando Health UF Health Cancer Center
Orlando, Florida, 32806
Investigator: Thomas Samuel Sajeve
Florida Cancer Specialists
Sarasota, Florida, 34236
Investigator: Caryn L Silver
Oncology-Hematology Associates of West Broward
Tamarac, Florida, 33321
Contact: 954-726-0035
Investigator: Sumit Sawhney
Northside Hospital
Athens, Georgia, 30606
Contact: 7063694478x5936
Investigator: Ali M Sayed
Tift Regional Health System Anita Stewart Oncology Center
Tifton, Georgia, 31794
Contact: 229-382-7120
Investigator: James E Milner
Beacon Cancer Care
Coeur d'Alene, Idaho, 83814
Contact: 208-755-2804
Investigator: David Bartels
Rush University Medical Center
Chicago, Illinois, 60612
Contact: 312-942-5904
Investigator: Marta Batus
Illinois Cancer Care
Peoria, Illinois, 61615
Contact: 309-243-3000
Investigator: Nguyet A Le-Lindqwister
James Graham Brown Cancer Center
Louisville, Kentucky, 40202
Contact: 502-852-2891
Investigator: Vivek Sharma
Hematology Oncology Clinic
Baton Rouge, Louisiana, 70809
Contact: 225-767-0822
Investigator: Gerald Miletello
Alton Ochsner Medical Center
New Orleans, Louisiana, 70121
Contact: 504-376-3863
Investigator: Marc R Matrana
University of Maryland, Baltimore
Baltimore, Maryland, 21201
Contact: 410-328-2703
Investigator: Amin Benyounes
SKCCC at Johns Hopkins
Baltimore, Maryland, 21287
Contact: 410-614-1361
Investigator: Stephanie Gaillard
Baltimore Washington Health Services
Glen Burnie, Maryland, 21061
Contact: 410-553-8360
Investigator: Harvinder Singh
University of Massachusetts Medical Center
Worcester, Massachusetts, 01655
Contact: 505-856-0056
Investigator: William Walsh
Henry Ford Macomb Hospital
Clinton Township, Michigan, 48038
Contact: 586-263-2269
Investigator: Malathy Kilaru
Cancer & Hematology Centers of Western Michigan
Grand Rapids, Michigan, 49503
Contact: 616-954-9800
Investigator: Judy Tsai
St. Luke's Hospital of Duluth
Duluth, Minnesota, 55805
Contact: 218-249-2567
Investigator: Homam Alkaied
Masonic Cancer Center, University
Minneapolis, Minnesota, 55455
Investigator: Domingo Musibay Evidio
Jackson Oncology Associates, PLLC
Jackson, Mississippi, 39202
Contact: 601-355-2485
Investigator: Justin T Baker
University of Mississippi Medical Center
Jackson, Mississippi, 39216
Investigator: Mildred Ridgway
County Oncologist, Inc.
Saint Louis, Missouri, 63136
Contact: 314-355-8200
Investigator: Juan O Carden
Cooper Hospital University Medical Center
Camden, New Jersey, 08103
Contact: 856-735-6289
Investigator: Polina Khrizman
Regional Cancer Care Associates, LLC
East Brunswick, New Jersey, 08816
Contact: 732-390-7750
Investigator: MICHAEL J. NISSENBLATT
Hudson Valley Cancer Center
Fishkill, New York, 12524
Contact: 845-896-8510
Investigator: Julia A Schaefer-Cutillo
SUNY Upstate Medical University
Syracuse, New York, 13210
Contact: 315-464-8230
Investigator: Poiesz Bernard
SUNY Upstate Medical University
Syracuse, New York, 13210
Contact: 315-464-8230
Investigator: Seth Rahul
East Carolina School of Medicine
Greenville, North Carolina, 27834
Contact: 252-756-5388
Investigator: DARLA LILES
Aultman Medical Group Hematology & Oncology
Canton, Ohio, 44710
Investigator: Shruti Trehan
University of Cincinnati Cancer Institute
Cincinnati, Ohio, 45219
Contact: 513-584-6373
Investigator: Amanda L Jackson
Cleveland Clinic Foundation
Cleveland, Ohio, 44195
Contact: 216-444-1128
Investigator: Dale Shepard
The James Cancer Hospital
Columbus, Ohio, 43210
Contact: 614-685-7377
Investigator: Gabriel R Tinoco
UPMC Hillman Cancer Center
Greenville, Pennsylvania, 16125
Contact: 724-589-4318
Investigator: Mukhtar O Hassan
Steward Sharon Regional Cancer Center
Hermitage, Pennsylvania, 16148
Contact: 724-983-5900
Investigator: Mukhtar O Hassan
UPMC Hillman Cancer Center
New Castle, Pennsylvania, 16105
Contact: 724-658-7300
Investigator: Amanda Laubenthal
Abramson Cancer Center at Pennsylvania Hospital
Philadelphia, Pennsylvania, 19106
Contact: 215-829-7089
Investigator: Lee Hartner
The West Clinic
Germantown, Tennessee, 38138
Contact: 901-683-0055
Investigator: David C Portnoy
Tennessee Oncology PLLC
Hixson, Tennessee, 37343
Contact: 4238760336
Investigator: Michael Anthony Stipanov
UVAHS Emily Couric Clin Cancer Ctr
Charlottesville, Virginia, 22903
Contact: 434-924-9333
Investigator: Leigh Cantrell
Kaiser Permanente of WA
Olympia, Washington, 98506
Contact: 360-923-7000
Investigator: Rachna Anand
Harrison HealthPartners Hematology
Poulsbo, Washington, 98370
Investigator: Toni Roberts
Seattle Integrative Cancer Center
Renton, Washington, 98360
Contact: 206-588-1722
Investigator: Naixi Chen
Mon Health Medical Center
Morgantown, West Virginia, 26505
Contact: 304-285-3870
Investigator: William C McBee
SSM Health Cancer Care Center
Madison, Wisconsin, 53717
Contact: 608-410-2700
Investigator: Lisa Lepeak
West Allis Memorial Hospital
West Allis, Wisconsin, 53227
Investigator: Elizabeth Dickson
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
1-317-615-4559
clinicaltrials.gov@lilly.com